AI assistant
OCULAR THERAPEUTIX, INC — Director's Dealing 2015
Sep 17, 2015
31615_dirs_2015-09-17_94fae225-cc9e-4faa-b6ef-e99b83a0c2c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OCULAR THERAPEUTIX, INC (OCUL)
CIK: 0001393434
Period of Report: 2015-09-15
Reporting Person: Fortune James (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-15 | Common Stock | S | 9470 | $17.16 | Disposed | 112060 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.49, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2: Includes 394 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan ("ESPP") on December 31, 2014 and 1,629 shares acquired under the ESPP on June 30, 2015.